Obesity is a relapsing condition that affects nearly 890 million adults across the world. It significantly contributes to death, illness, and healthcare cost to large population. Among available treatments, GLP-1 receptor agonists have become a core part of obesity pharmacotherapy.  Tripeptide, a GIP/GLP-1 receptor agonist, was initially approved for type 2 diabetes but is now showing greater weight-loss effects. New research trials suggested that participants with obesity w

As medical weight reduction treatments become more popular, a lot of people are wondering if prescription weight-loss drugs are really worth the money. Diet and exercise are still important, but they don't always work for everyone, especially people who have hormonal imbalances, a slow metabolism, or are gaining weight all the time. Prescription weight-loss drugs are a scientifically sound option, but you need to look more closely at how they operate, how much they cost, and